HomeSUPN • NASDAQ
add
Supernus Pharmaceuticals Inc
Previous close
$32.84
Day range
$31.46 - $32.90
Year range
$25.53 - $40.28
Market cap
1.77B USD
Avg Volume
615.38K
P/E ratio
24.26
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 174.16M | 5.99% |
Operating expense | 128.50M | 2.23% |
Net income | 15.33M | 1,204.51% |
Net profit margin | 8.80 | 1,139.44% |
Earnings per share | 0.55 | -38.46% |
EBITDA | 38.41M | -5.56% |
Effective tax rate | 41.90% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 453.61M | 77.97% |
Total assets | 1.37B | 7.08% |
Total liabilities | 332.34M | -6.69% |
Total equity | 1.04B | — |
Shares outstanding | 55.81M | — |
Price to book | 1.77 | — |
Return on assets | 3.61% | — |
Return on capital | 4.62% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 15.33M | 1,204.51% |
Cash from operations | 44.41M | -1.23% |
Cash from investing | -12.64M | 80.85% |
Cash from financing | 5.89M | 439.38% |
Net change in cash | 37.66M | 288.94% |
Free cash flow | 39.03M | -19.48% |
About
Founded
2005
Headquarters
Website
Employees
674
